Birdwatch Note Rating
2024-08-14 01:49:20 UTC - HELPFUL
Rated by Participant: 5BCE7BB2270B05D07642BE87B001C92F39283A7882BD538986EA185D19594FEC
Participant Details
Original Note:
The scholarly articles have report "...These results suggest that a third dose of BNT162b2 is safe, improves humoral immunity against SARS-CoV-2, and could be immunologically beneficial for cancer patients on active chemotherapy." : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004706/ A scientific study is needed NOT speculation
All Note Details